EPS Creative Health Technology Group Limited provided group earnings guidance for the year ended 31 March 2022. Based on the preliminary assessment of the unaudited consolidated management accounts of the group for the year ended 31 March 2022 and the other information currently available to the board, such loss-making is also expected to continue and be reflected in the remaining months in the year ended 31 March 2022. The group is expected to record a loss attributable to shareholders for the year ended 31 March 2022 in the range of HKD 12 million to HKD 14 million, as compared to the profit attributable to Shareholders of approximately HKD 6.5 million for the year ended 31 March 2021.

Such loss is also mainly attributable to the same reasons as disclosed above and in the interim report. Despite the above, the board considers that the group's financial position remains strong.